Top Market Insights Stories
Market Insights
Health insurers balk at Biogen's $56,000-a-year Alzheimer's treatment
By John Tozzi, Angelica LaVito and Anushree DavePrivate insurers say they need more evidence that the treatment actually slows the rate at which Alzheimer's patients deteriorate.










